Osaic Holdings
TNXP icon

Osaic Holdings’s Tonix Pharmaceuticals TNXP Stock Holding History

Osaic Holdings’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20K Sell
1,455
-90
-6% -$1.39K ﹤0.01% 5859
2025
Q4 		$24.1K Buy
1,545
+3
+0.2% +$55 ﹤0.01% 5752
2025
Q3 		$39.1K Buy
1,542
+1,035
+204% +$38.4K ﹤0.01% 5473
2025
Q2 		$18.2K Buy
507
+380
+299% +$9.96K ﹤0.01% 5782
2025
Q1 		$2.27K Buy
127
+22
+21% +$446 ﹤0.01% 6541
2024
Q4 		$3.47K Buy
+105
New +$2.18K ﹤0.01% 6378
2024
Q2 		– Hold
0
– -$6 – 7617
2024
Q1 		– Hold
0
– – – 7156
2023
Q4 		– Hold
0
– – – 6991
2023
Q3 		– Hold
0
– – – 6984
2023
Q2 		– Hold
0
– – – 6757
2023
Q1 		– Hold
0
– – – 6502
2022
Q4 		– Hold
0
– – – 6963
2022
Q3 		– Hold
0
– – – 7073
2022
Q2 		– Hold
0
– – – 6941
2022
Q1 		– Hold
0
– – – 3920
2021
Q4 		– Hold
0
– – – 6152
2021
Q3 		– Hold
0
– – – 5781
2021
Q2 		– Hold
0
– – – 6263
2021
Q1 		– Hold
0
– – – 5989
2020
Q4 		– Hold
0
– – – 6275
2020
Q3 		– Hold
0
– – – 6080
2020
Q2 		– Hold
0
– – – 5992
2020
Q1 		– Hold
0
– – – 5209

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Osaic Holdings's TNXP Position: Q1 2026 in Review

Osaic Holdings reduced its Tonix Pharmaceuticals (TNXP) stake by 5.8% in Q1 2026, selling an estimated $1.39K and leaving 1,455 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #5859.

Osaic Holdings first reported a position in TNXP in Q4 2024 and has held it in 6 quarters since. The position peaked at $39.1K in Q3 2025. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • Osaic Holdings held 1,455 shares of Tonix Pharmaceuticals worth $20K as of Q1 2026.
  • Osaic Holdings sold 90 Tonix Pharmaceuticals shares in Q1 2026, an estimated $1.39K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5859 holding.
  • Osaic Holdings first reported a position in Tonix Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Osaic Holdings's Tonix Pharmaceuticals position peaked at $39.1K in Q3 2025.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.